Meeting poor people’s needs for access to medicines through responsible business practices
(Click to enlarge)
The pharmaceutical industry is increasingly looking to the potentially huge markets within emerging economies. Yet, poor people who live in these countries still desperately lack affordable and appropriate medicines. This paper argues that the industry must put access to medicines at the heart of its decision-making and practices. This is both a more sustainable long-term business strategy and would allow the industry to better play its role in achieving the universal right to health.